ProShares Ultra Nasdaq Biotechnology (BIB)
Add to Watchlists Create an AlertProShares Ultra Nasdaq Biotechnology Performance
Historical performance is a good guide for the future, but it is imperfect. Pay attention to a company's history, but be realistic about what you can project into the future.
BIB Total Returns Comparison
Here are ProShares Ultra Nasdaq Biotechnology's total returns compared to the market and some of its peers. High historical total returns are excellent - especially if you held the stock at the time - but returns can change direction quickly. To predict future performance, looking at the business is more important than looking at historic returns.
| 1 month returns | YTD returns | 1 year returns | 3 year returns | |
|---|---|---|---|---|
| ProShares Ultra Nasdaq Biotechnology | 7.75% | 72.84% | 110.2% | 342.4% |
| S&P 500 Total Return | 5.95% | 16.80% | 28.33% | 61.97% |
| ProShares Ultra MSCI EAFE | 0.01% | 11.23% | 59.23% | 50.05% |
| ProShares Ultra Dow30 | 8.61% | 38.54% | 53.63% | 134.3% |
BIB Total Returns Performance
Returns from price appreciation only give a partial view of the returns to an investor. This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested)
BIB News
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| BIB | 99.71 | +0.48 | +0.48% |
